Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Biosenta Inc. C.ZRO

Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and industrial applications, utilizing advanced encapsulated nanotechnology. It also develops chemical compounds designed to eliminate harmful microorganisms, such as bacteria, fungi, and viruses for household and industrial uses, while ensuring safety for both humans and the... see more

CSE:ZRO - Post Discussion

Biosenta Inc. > What we need?
View:
Post by jjnard26 on Jan 19, 2021 5:50pm

What we need?

A lucrative underwriting deal.
Comment by Bandit22 on Jan 20, 2021 5:11am
Yes. You're right. The previous news releases talked about royalties that were expected to increase based on our deal with Kleen Bee Labs. Obviously, increased sales are the way to get increased royalties.  It doesn't take a rocket scientist to figure out that we must have some sales happening and revenue coming in... ***This was back in June 2020*** Am Gill, President and CEO ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities